Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.04. | Xebra Brands Ltd (2): Xebra receives second CBD product approval by COFEPRIS | 2 | Stockwatch | ||
16.04. | Xebra Brands receives second CBD approval by COFEPRIS | 1 | The Market Herald Canada | ||
16.04. | Xebra Brands Ltd: Xebra Brands Receives Second CBD Product Approval by COFEPRIS | 193 | ACCESSWIRE | Xebra Expands Elements Brand of CBD products for Mexican Consumers VANCOUVER, BC / ACCESSWIRE / April 16, 2024 / Xebra Brands Ltd. (CSE:XBRA)(OTCQB:XBRAD)(FSE:9YC0) ("Xebra" or the "Company"), a leading... ► Artikel lesen | |
04.04. | Xebra Brands Ltd (2): Xebra submits new CBD product for approval in Mexico | 3 | Stockwatch | ||
04.04. | Xebra Brands provides third product submission to COFEPRIS | 1 | The Market Herald Canada | ||
04.04. | Xebra Brands Ltd: Xebra Brands Submits Third Product Submission to COFEPRIS, Expanding Elements Brand CBD Lineup | 353 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / April 4, 2024 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading company in the CBD and cannabis industry, is proud to announce... ► Artikel lesen | |
26.03. | Xebra Brands Ltd (2): Xebra Brands signs manufacturing deal with Restorative | 5 | Stockwatch | ||
26.03. | Xebra Brands Ltd Executes Manufacturing Agreement with Restorative Botanicals | 203 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / March 26, 2024 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a cannabis company, is excited to announce the signing of a manufacturing... ► Artikel lesen | |
21.03. | Xebra Brands Ltd (2): Xebra closes shares-for-debt deal, grants options | 3 | Stockwatch | ||
21.03. | Xebra Brands Ltd: Xebra Brands Announces Closing of Shares for Debt Transaction and Grants Options | 327 | ACCESSWIRE | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESVANCOUVER, BC / ACCESSWIRE... ► Artikel lesen | |
12.03. | Xebra Brands and KannaGroup to develop CBD products in Mexico | 3 | The Market Herald Canada | ||
12.03. | Xebra Brands Ltd (2): Xebra, KannaGroup to manufacture CBD products in Mexico | 2 | Stockwatch | ||
12.03. | Xebra Brands Ltd: Xebra Brands Partners with KannaGroup to Manufacture CBD Products in Mexico | 237 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 12, 2024) - Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC0) ("Xebra" or the "Company"), Xebra Brands, a leading player in the CBD industry... ► Artikel lesen | |
07.03. | Xebra Brands Ltd (2): Xebra Brands to settle $262,712 debt with shares | 4 | Stockwatch | ||
07.03. | Xebra Brands Ltd: Xebra Brands Announces Closing of Non-Brokered Private Placement of Units and Shares for Debt Settlement | 324 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 7, 2024) - Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC0) ("Xebra" or the "Company"), a cannabis company, is pleased to announce that... ► Artikel lesen | |
29.02. | Xebra Brands Ltd (2): Xebra submits two new products for approval in Mexico | 4 | Stockwatch | ||
29.02. | Xebra Brands Ltd: Xebra Brands Submits Two New Products to COFEPRIS for Approval, Expanding CBD Offerings in Mexico | 373 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 29, 2024) - Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC0) ("Xebra" or the "Company"), a cannabis company, is pleased to announce the... ► Artikel lesen | |
27.02. | Xebra Brands receives its first approval for legal CBD in Mexico | 1 | The Market Herald Canada | ||
27.02. | Xebra Brands Ltd (2): Xebra Brands authorized to import, sell CBD in Mexico | 1 | Stockwatch | ||
27.02. | Xebra Brands Ltd: Xebra Brands Receives Its First-Ever Federal Authorization for Legal CBD Launch in Mexico | 241 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 27, 2024) - Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAD) (FSE: 9YC0) ("Xebra" or the "Company"), a cannabis company, announces that it has been... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 27,950 | -0,64 % | Enorme Fortschritte - First Majestic Silver, Power Nickel, Bayer Aktie | In den vergangenen Wochen sind die Rohstoffe und Rohstoffaktien im Zuge der Gold- und Silberrally in den Fokus der Anleger gerückt. Viele Aktien aus den beiden Sektoren konnten sich von ihren Tiefstständen... ► Artikel lesen | |
AURORA CANNABIS | 6,555 | +0,69 % | Aurora Cannabis & Canopy Growth stürzen ab - was ist los? | Um mehr als -20% sind am deutschen Feiertag die Aurora Cannabis-Aktie (WKN: A2P4EC) und die Aktie von Canopy Growth (WKN: A140WQA) an der Nasdaq abgestürzt. Was ist los im Cannabis-Sektor? Und wie geht... ► Artikel lesen | |
CANOPY GROWTH | 9,550 | -1,44 % | Breaking News: Marihuana-Hammer - Tilray, Curaleaf, Canopy & Co explodieren | Das kommt überraschend: In Amerika ändert sich die Einschätzung von Marihuana. Die Drogenbehörde DEA ändert ihre Einstufung von Marihuana auf Schedule III. Damit erkennt sie die medizinische Verwendung... ► Artikel lesen | |
TILRAY BRANDS | 1,915 | +1,92 % | Tilray Just Soared 40% This Week: Is the Stock a Good Buy Now? | ||
INNOCAN PHARMA | 0,189 | +1,34 % | Achtung! CEO lässt auf "X" die Bombe platzen! | ||
CRONOS GROUP | 2,488 | +0,08 % | Why Canopy Growth, Tilray, and Cronos Group Stocks Just Cratered | ||
SYNBIOTIC | 9,400 | -1,67 % | ANLEIHEN-Woche KW17 - 2024: ABO Wind, Groß & Partner, Greencells, ELARIS, FCR Immobilien, Ekosem-Agrar, Werder Bremen, Mutares, paragon, NEON EQUITY, MS Industrie, pferdewetten, Homann Holzw., SynBiotic, Energiekontor, Dt. Rohstoff, LEEF, … | Kalenderwoche 17 am KMU-Anleihemarkt (22.04. bis 26.04.2024) - der erste Green Bond der ABO Wind AG (ISIN: DE000A3829F5) erfährt eine hohe Investoren-Nachfrage in der aktuellen Zeichnungsphase. Das... ► Artikel lesen | |
CHRISTINA LAKE CANNABIS | 0,013 | -44,44 % | Christina Lake Cannabis Corp.: Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO | ||
ORAMED PHARMACEUTICALS | 2,170 | -0,78 % | Oramed Pharmaceuticals Inc.: Oramed Letter to Shareholders | Initiating Phase 3 oral insulin trial in the United States under a new protocol
JV with Chinese Partner, HTIT
Scilex Senior Secured Note
PeriTech Asset Purchase & Strategic Out-licensing
NEW... ► Artikel lesen | |
NEKTAR THERAPEUTICS | 1,608 | +3,61 % | Nektar Network Begins Epoch 1 of Nektar Drops - Rewards for Ongoing Participation | ||
OPKO HEALTH | 1,191 | +3,24 % | OPKO Health, Inc.: AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV | • Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans• Candidate showed similar half-life to standard monoclonal antibodies... ► Artikel lesen | |
JAGUAR HEALTH | 0,330 | +20,28 % | Jaguar Health, Inc.: Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion About Microvillus Inclusion Disease | Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome (SBS) with intestinal... ► Artikel lesen | |
SELLAS LIFE SCIENCES | 1,264 | +0,80 % | SELLAS Life Sciences Group, Inc.: SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level | - The Company Filed IP Protection Related to the ASXL1 Mutation, a Highly Prevalent Gene Mutation in Myeloid Malignancies and Solid Tumors With Significant Market Potential - - 100% Overall Response... ► Artikel lesen | |
XORTX THERAPEUTICS | 2,570 | +1,98 % | XORTX ändert Preis von Warrants, die im Rahmen früherer Privatplatzierungen ausgegeben wurden | CALGARY, AB - 30. April 2024 / IRW-Press / XORTX Therapeutics Inc. ("XORTX" oder das "Unternehmen") (NASDAQ: XRTX | TSXV: XRTX | FWB: ANU), ein auf spätklinische Studien spezialisiertes... ► Artikel lesen | |
NUMINUS WELLNESS | 0,045 | -8,89 % | Numinus Wellness Inc.: Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003 | VANCOUVER, BC, April 17, 2024 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral... ► Artikel lesen |